Category: Innovalve

Edwards Lifesciences (NYSE: EW) today announced that it has exercised its option to acquire an early-stage Israeli transvascular coronary angioplasty company Inovalife Biomedical IndustriesNo financial details were disclosed, but the acquisition is estimated to be worth hundreds of millions of dollars. Innovalve was founded at the Sheba Medical Center in…